GIP receptors in skeletal muscle may also reduce protein breakdown during caloric restriction, part of why tirzepatide shows slightly better muscle preservation than semaglutide at matched weight loss
A Healthline review notes that while GI side effects are common, they often lessen over time as your body adjusts to the medication
Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management and chronic weight management in adults with obesity or overweight with weight-related comorbidities
Significant increases of blood flow to exercising muscles may provide training benefits for some athletes during certain types of competition or physical conditioning
Mauldin | Jul 27 2026 01:31 If youre taking Ozempic, Wegovy, Mounjaro, or Zepbound and worrying that one prescription could wreck your life insurance application, heres the truth: for many people in Lexington and across the Midlands, that fear is bigger than the actual problem